Health Products

NDarvon-N

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Unacceptable risk to health
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCommon nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
448607NDarvon-N
Recalling Firm
Paladin Labs Inc. / Distributor 6111 Royalmount Ave., Suite 102 Montreal, Quebec H4P 2T4
Marketing Authorization Holder
Paladin Labs Inc. 6111 Royalmount Ave., Suite 102 Montreal, Quebec H4P 2T4
Recalling Firm
Paladin Labs Inc. / Distributor
CapsulesDIN 00261432100 mg

Introduction

Recalled products
  1. NDarvon-N

Reason

Paladin has decided to recall all lots of NDarvon-N® (dextropropoxyphene, also known as propoxyphene) on the Canadian market and discontinue the sale of the product following the US FDA request for withdrawal of all propoxyphene containing products due to new data showing that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA concluded that the safety risks of propoxyphene products outweigh its benefits for pain relief at recommended doses.

Depth of distribution

Wholesalers and pharmacies across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime